The MRI shows a brain tumor in an inauspicious location, and a brain biopsy will entail high risks for a patient who had ...

A newly developed molecular imaging technique can identify multiple subtypes of triple-negative breast cancer (TNBC), ...

Recent advances in cancer research have underscored the critical role of myeloid cells in shaping tumor microenvironments ...

Sequencing of ctDNA was performed on blood samples through Guardant360 from the 243 patients with GIST (198 de-identified from the Guardant Health database and 45 from Sylvester Comprehensive Cancer ...

Sanofi to acquire Blueprint Medicines for up to $9.5B to expand its rare immunological disease portfolio, including an ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...

New techniques used to analyze soft tissue in dinosaur fossils may hold the key to new cancer discoveries, according to a ...

Antitumor therapies have conventionally been evaluated based on their capacity to eliminate malignant cells. However, growing evidence highlights that drugs ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous squamous cell carcinoma (cSCC), the most common type of metastatic skin cancer.

Preclinical data has showing compelling findings for HT-KIT among patients with rare and aggressive KIT-driven cancers, ...

As scientists question the rise in early colon cancer cases, a new study is offering some potential answers. Colored scanning electron micrograph (SEM) of a macrophage white blood cell (center ...

Immunotherapy has developed rapidly in solid tumors, especially in the areas of blocking inhibitory immune checkpoints and adoptive T-cell transfer for immune regulation. Many patients benefit from ...